FTC Acts to Stop Two Companies from Making Unproven Bone and Joint Claims

The Federal Trade Commission sued two companies to stop them from continuing to deceive consumers with false claims that their pills are scientifically proven to alleviate joint pain by growing new bone and cartilage.

The FTC filed a complaint against ZyCal Bioceuticals, that has marketed a line of joint pain relief products under the brand name Ostinol. The same complaint includes allegations against another company Excellent Marketing Results, Inc. (EMR), which marketed a pill called StimTein through infomercials and online.

Read more here.